Legacy Financial Advisors, Inc. Edwards Lifesciences Corp Transaction History

Legacy Financial Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$55.74 - $64.41 $4,793 - $5,539	-86 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $670 - $896	14 Added 19.44%	86 $16,000
Q2 2018 Jul 17, 2018	BUY	$42.45 - $51.3 $3,056 - $3,693	72 New	72 $11,000
Q1 2018 Apr 12, 2018	SELL	$37.19 - $47.45 $2,677 - $3,416	-72 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$33.79 - $39.39 $2,432 - $2,836	72	72 $8,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.